Advanced Prostate Cancer Clinical Trial Research: A Decade of Progress and the Road Ahead Webinar (2026)
Availability
Registration Required
Online Meeting
Sep 29, 2026 8:00 PM - 9:00 PM ET
Cost
$0.00
Credit Offered
No Credit Offered
Clinical trial research advances have been pivotal to the ongoing optimization of advanced prostate cancer management throughout the past decade. Continued clinical trial research will be equally important in the decade ahead and beyond as urologists and oncologists continue to advance new and improved treatment strategies for advanced prostate cancer. As the decade behind has been defined by immense progress, and the decade ahead poised with great promise - education on the landmark, latest, and upcoming clinical trials for advanced prostate cancer is critical at all career stages. Made possible by a generous endowment from Chesapeake Urology Associates, “Advanced Prostate Cancer Clinical Trial Research: A Decade of Progress and the Road Ahead” brings together some of urology’s leading independent practice clinical trial investigators for 60-minute, live webinar exploring clinical trial research updates in advanced prostate cancer.
Support provided by a Urology Care Foundation endowment fund made possible by Chesapeake Urology Associates.
  • Urologists
  • Residents
  • Post-Doctoral and Research Fellows
  • Clinical Fellows
  • Researcher/Scientist

After participating in this activity, participants will be able to:

  1. Apply guidance from the Prostate Cancer Clinical Trials Working Group 4 in interpreting recent advanced prostate cancer clinical trial results.
  2. Consider integration of new and emerging technologies and therapies into current advanced prostate cancer research and future clinical practice to ultimately improve patient outcomes.
  3. Enhance current advanced prostate cancer clinical trial research efforts through integration of artificial intelligence and digital oncology approaches.
  4. Address evidence gaps and unanswered questions into current and future clinical trial research efforts for advanced prostate cancer.